手术切除的N2期非小细胞肺癌预后影响因素分析
摘要
但未累及对侧纵隔、肺门或同侧斜角肌淋巴结的肺癌。手术切除是N2期非小细胞肺癌的主要治疗手段之一,但患者
的预后差异显著。因此,分析影响N2期非小细胞肺癌手术切除患者预后的因素,对于提高治疗效果、延长患者生存
期具有重要意义。
关键词
全文:
PDF参考
[1]Fu Fangqiu, Sun Wenrui, Bai Jinsong, Deng
Chaoqiang, Zheng Difang, Li Yuan, Zhang Yang, Chen
Haiquan. Long-Term Outcomes of Selected Patients with
IIIA-N2Non-small Cell Lung Cancer Receiving Upfront
Surgical Resection[J]. Annals of surgical oncology, 2023,
30(13): 8261-8270.
[2]Lee Jang Hyuck, Park JiEun, Hong MiJeong, Choi
JinEun, Kang HyoGyoung, Do SookKyung, Lee Sunwoong,
Jeong JiYun, Shin KyungMin, Do YoungWoo, Lee EungBae,
Lee WonKee, Oh InJae, Kim YoungChul, Choi SunHa, Lee
YongHoon, Seo Hyewon, Lee Jaehee, Cha SeungIck, Kim
ChangHo, Yoo SeungSoo, Lee ShinYup, Park JaeYong. Gen
eticvariantsinkeynecroptosisregulatorspredictprognosisofnonsmallcelllungcanceraftersurgicalresection.[J]. Thoraciccancer,
2023, 14(26): 2678-2686.
[3]Müller Christin, Taber Samantha, Pfannschmidt
Joachim, Griff Sergej. ExtracapsularextensionofpN2ly
mphnodemetastasesisnotprognosticallysignificantinsur
gicallyresectedpatientswithnon-smallcelllungcancer[J].
InnovativeSurgicalSciences, 2023, 8(1):9-16.
[4]Azzoli Christopher, Huynh Lynn, Yi Denise, Duh
Mei S, Cai Beilei. Authors' Responseto "Letter to the
Editor" Submittedby S.Wangand W.Liu(re:"Retrospective
Study to Examine Prognostic Valueof C-Reactive Proteinin
Patients With Surgically Resectable Non-Small-Cell Lung
Cancer"[J]. Clinicallungcancer, 2023, 24(6): e197-e197.
[5]Wang Sujuan, Liu Wenqing. Commentson"Retrospective Study to Examine Prognostic Valueof
C-Reactive Proteinin Patients With Surgically Resectable
Non-Small Cell Lung Cancer"[J]. Clinicallungcancer, 2023,
24(6): e195-e196.
[6]Liu Wenliang, Ren Siying, Zeng Chao, Hu
Yan. Prognosticvalueofperineuralinvasioninresectednonsmallcelllungcancer:Ameta-analysis[J]. Heliyon, 2023, 9(4):
e15266-e15266.
[7]Mazzella Antonio, Maiolino Elena, Maisonneuve
Patrick, Loi Mauro, Alifano Marco. Systemic Inflammationand
Lung Cancer: Is Ita Real Paradigm? Prognostic
ValueofInflammatory Indexesin Patientswith Resected NonSmall-CellLung Cancer[J]. Cancers, 2023, 15(6): 1854-1854.
[8]Kang Seung Wan, Jeong Won Gi, Lee Jong Eun,
Oh In Jae, Song Sang Yun, Lee Byung Chan, Kim Yun
Hyeon. Prognosticsignificanceoflocationindexinresected T1-
sizedearly-stagenon-smallcelllungcancer[J]. Acta Radiologica,
2023, 64(3): 1028-1037.
[9]Azzoli Christopher, Huynh Lynn, Yi Denise,
Duh Mei S, Cai Beilei. Retrospective Studyto Examine
Prognostic Valueof C-Reactive Proteinin Patients With
Surgically Resectable Non-Small-CellLung Cancer.[J].
Clinicallungcancer, 2023, 24(4): 329-338.
[10]Zeng Yuan, Liu Jun, Wan Minghui, Li Qiwen, Liu
Hui, Cui Fei, Hao Zhexue, Wang Wei, Jiang Long, Liang
Wenhua, He Jianxing. Theassociationofpostoperativeradiot
herapywithsurvivalinresectedN2non-smallcelllungcancer[J].
Journalofthoracicdisease, 2023, 15(1): 42-53.
[11]T.Miyoshi, A.Hamada, J.Soh, A.Hata, K.Nakamatsu,
M.Shimokawa, Y.Yatabe, J.Suzuki, M.Tsuboi, H.Horinouchi,
I.Yoshino, T.Masayuki, S.Toyooka, M.Okada, T.Go,
M.Yamashita, Y.Nishimura, N.Yamamoto, K.Nakagawa,
T.Mitsudomi. 124PPhaseIIstudyofneoadjuvantconcurrentche
mo-immuno-radiationtherapyfollowedbysurgeryandadjuvan
timmunotherapyforresectablestageIIIA-BN2non-smallcelllun
gcancer:SQUATtrial(WJOG12119L)[J]. Immuno-Oncology
and Technology, 2022, 16(S1):100236-.
[12]余军林,崔抗,李向荣.放化疗对手术切除的
Ⅰb期非小细胞肺癌患者预后的影响[J].肿瘤基础与临
床,2023,36(06):465-471.
[13]牛新燕,方香香,索仲.手术切除的N2期非小
细胞肺癌预后影响因素分析[J].实用癌症杂志,2023,38
(08):1270-1272+1316.
[14]吴茂芳,石汶,肖寿勇,蔡静静,刘曾平,方
红.ⅢA/N2期非小细胞肺癌患者术后放疗的倾向评分匹
配分析[J].大理大学学报,2023,8(08):64-70.
[15]李润锋.基于SEER数据库的ⅢA-N2期非小细
胞肺癌患者预后分析及预后模型构建[D].南方医科大学,
2023.
[16]赵豪南.可切除的ⅢAN2期非小细胞肺癌术后复
发独立因素分析及不同辅助治疗预后差异研究[D].广州
医科大学,2023.
Refbacks
- 当前没有refback。